Chenguang Biotech Group Capital Reinvestment Ratio
Chenguang Biotech Group capital reinvestment ratio. Chenguang Biotech Group (300138) has a Capital Reinvestment Ratio of 0.07x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥524.96 Million) in capital expenditures (CN¥37.63 Million). Check Chenguang Biotech Group investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Chenguang Biotech Group (2008–2025)
Capital reinvestment ratio of Chenguang Biotech Group from 2008 to 2025. This chart tracks Chenguang Biotech Group's Capital Reinvestment Ratio across 8 annual periods. Also explore net asset growth rate of Chenguang Biotech Group to track the company's year-over-year net asset growth rate.
Chenguang Biotech Group Capital Reinvestment Ratio by Year (2008–2025)
Chenguang Biotech Group capital reinvestment ratio by year from 2008 to 2025. For the full cash flow conversion analysis, see Chenguang Biotech Group (300138) cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.64x | CN¥212.91 Million | CN¥135.26 Million | ▲ +165.2% |
| 2022 | 0.24x | CN¥734.81 Million | CN¥176.03 Million | ▼ -94.5% |
| 2021 | 4.39x | CN¥63.90 Million | CN¥280.82 Million | ▲ +432.5% |
| 2020 | 0.83x | CN¥529.41 Million | CN¥436.88 Million | ▲ +515.0% |
| 2014 | 0.13x | CN¥272.96 Million | CN¥36.62 Million | ▼ -93.9% |
| 2011 | 2.21x | CN¥82.18 Million | CN¥181.72 Million | ▼ -10.0% |
| 2009 | 2.46x | CN¥27.23 Million | CN¥66.90 Million | ▼ -14.5% |
| 2008 | 2.87x | CN¥9.06 Million | CN¥26.05 Million | — |